To date the effectiveness of antibiotics is undermined by microbial resistance, threatening public health worldwide. The possible failure of conventional antibiotics engenders the need for new drugs, with demanding investments of money, labor and time. Enhancing the efficacy of the current antibiotic arsenal is an alternative strategy. The administration of antimicrobials encapsulated in nanocarriers, such as liposomes, is considered a viable option, though with some drawbacks related to limited affinity between conventional liposomes and bacterial membranes.
Introduction
Infectious diseases continue to represent one of the greatest health challenges worldwide, despite the advancements in understanding the disease mechanisms and extensive efforts in the design of new drugs. Antibiotics, the most important class of bioactive compounds against microbes, have been used to treat infections from immemorial time. However, from the very beginning of antibiotic utilization, their effectiveness was undermined by development of microbial resistance. [1] [2] [3] [4] [5] Two reports issued in 2014 by World Health Organization show that resistance against antibiotics hampers the prevention and treatment of a wide range of infections 6 and recommend measures for best practice prescription. 7 Indeed, fast bacterial adaptability to new environmental conditions and mobilization of resistome genes imply that all antibiotics in clinical use may have microbes able to resist them. [8] [9] [10] The failures of antibiotic therapy contribute to thousands of deaths annually. [11] [12] To face problems related to the use of antimicrobial agents, high doses of antibiotics or development of new drugs are continuously required. 13 In this contest, a viable strategy is to enhance the efficacy of the current antibiotic arsenal. For instance, the administration of bioactive compounds encapsulated in nanoparticles, [14] [15] [16] [17] and liposomes, [18] [19] [20] [21] has been indicated as a promising approach. These vectors can protect antibiotics against deactivation and help to overcome physiological barriers, thus facilitating transport and allowing for slow release at the target site. This in turn improves drug bioavailability while limiting side effects. [22] [23] [24] [25] In particular, liposomes and lipid-based nanoparticles exhibit low toxicity combined with high therapeutic efficacy, particularly for poorly soluble drugs. 26 Liposomes are able to interact with the bacterial outer membrane (OM) and lipopolysaccharides of Gram-negative bacteria, thus facilitating the internalization of drugs 27, 28 at a concentration high enough to overcome transmembrane pumps that catalyze increased efflux of drug out of the bacterial cell. 16 As reported by several authors, liposome-OM fusion is often associated with minimum inhibitory concentration (MIC) reduction compared to free antibiotics. 19 For example, Mugabe et al. 29 demonstrated the liposomebacterial membrane fusion by applying different techniques. The liposomal 4 formulation used by these authors contained aminoglycosides and polymyxin B and was able to reduce MICs by 4-16 times in a high-resistant strain of P.aeruginosa. Rukholm et al. 30 reported that liposomal containing gentamicin show better antipseudomonal activity than the free drug, with a 16-fold MIC reduction.
Moreover, prevention of biofilm formation and/or its destruction 14, 31 and treatment of intracellular bacterial infections could benefit from the use of nanovectors. 32, 33 Therefore, in the perspective of enhancing delivery of currently used antibiotics, there is an urgent need for ad-hoc designed lipid vectors, highly compatible with the biological membranes and synthesizable through low cost processes.
Liposomal carriers are usually prepared though a "bottom up" approach, consisting of the assembled single lipid components. Here we devised a "top-down" procedure to obtain unconventional liposome from microbial phospholipid, in the belief that the composition of lipid-based vectors plays a major role in the interactions with pathogen microorganisms. [34] [35] [36] The lipid fraction was thus extracted from bacteria and used to build novel liposome formulations (Prokaryote Derived-liposomes, PDliposomes). Similar systems were prepared by Gupta et al. to encapsulate carboxyfluorescein as a model molecule for anticancer drug delivery. 37 More generally, the aptitude of vesicles produced by bacterial membranes to perform a variety of functions, including DNA delivery, has been pointed out in a recent review. 38 It is also known that Gram-negative bacteria naturally produce outermembrane vesicles, which accomplish a variety of functional roles. 39, 40 In this paper we chose Gram-negative purple non sulfur bacteria and cyanobacteria, which can be found in several ecological niches 41, 42 and are already used for biotechnological processes. [43] [44] [45] Thanks to great versatility and limited growth requirements, 46, 47 these bacteria produce large amounts of biomass that may represent a valuable and low-cost byproduct for scalable liposomes production. In depth physicochemical characterization was performed to investigate the structural properties of PD-liposomes. Their ability to overcome resistance against antibiotics was compared with to standard liposomes (Std-liposomes). Penicillins and Escherichia coli were used as antibiotics and test organism, respectively. Penicillins belong to β-lactam antibiotics, widely used for their high effectiveness, low cost, ease of 5 delivery and minimal side effects. 48 Indeed, the emergence of resistance to penicillins places high demand for ways to improve the effectiveness of this important class of antibiotics. 49 We thus propose PD-liposomes to contrast reduced uptake and enzymatic degradation of penicillins and show the effectiveness of these unconventional carriers in helping penicillins to overcome the OM barrier in E. coli.
Materials and methods

Chemicals
Ampicillin trihydrate (96-100% purity, anhydrous basis, henceforth called Amp) 
Bacterial strains and growth conditions
The microorganisms used to prepare bacterial lipid vectors were (i) the unicellular Cyanothece sp., strains CCY0110 and VI22, isolated from marine and saline 6 habitats respectively, and (ii) the purple non-sulfur photosynthetic bacterium, Rhodopseudomonas palustris, strain 42OL, isolated from a pond containing wastewaters of a sugar refinery. All the bacterial strains belong to the specialized culture collection of the Department of AgriFood Production and Environmental Sciences (University of Florence, Italy). The Cyanothece strains are N2-fixing gramnegative bacteria able to produce extracellular slimes of polysaccharidic nature. In particular, VI22 strain, excrete extracellular polysaccharides which are structured as thick capsules surrounding the cells, while the CCY0110 releases the majority (~75%) of the polysaccharides in the surrounding medium and does not form outermost structures. 50 Inversely, the R. palustris strain 42OL is a Gram-negative bacterium not able to accumulate exo-polysaccharides. 51 Cyanothece sp., strains CCY0110 (henceforth indicated as CCY) and VI22 were grown in ASN-III medium 52 and enriched seawater medium (AMA), 41 respectively; R. palustris, strain 42OL was grown anaerobically in RPN medium. 53 The E. coli XL1Blue strain (Stratagene, La Jolla, CA, USA), with or without pUC18 plasmid, 54 was used to test the antimicrobial activity of antibiotic preparations. E. coli XL1Blue cells were cultured aerobically at 37°C in Luria Broth (LB) complex medium. 55 2. Specifically, the SAXS pattern of bilayer-based structures is modeled by:
where Ndiff is the fraction number of single-bilayer vesicles, S(q) is the structure factor describing the inter-particle interactions and P(q) is the absolute square of
the bilayer form factor. The electron density is described by three-Gaussians (Scheme 1), representing the polar heads, placed at ± zH, and the hydrocarbon core. The standard deviation of these distributions are σH and σc, respectively. The terminal methyl group in the bilayer center corresponds to the minimum of the electron density. rH is the amplitude of the hydrophobic tails. 
Structural characterization of plain and loaded PD-liposomes
As liposomes prepared from bacterial lipids were shown to be valuable carriers to increase the delivery of PenG, we proceeded to their structural characterization.
Dynamic Light Scattering is a straightforward and suitable tool to evaluate the mean size and size distribution of isolated nano-objects in solution. In the case of liposomal drug delivery these properties are known to influence liposome stability, drug entrapment and delivery efficacy. The results obtained for plain and antibioticassociated liposomes are reported in Table 1 .
All solutions contained scattering objects with a fairly large size distribution, by DLS data, the overall size of PD-liposomes was too large to be accessed by SAXS, however this technique was able to provide detailed information on the bilayer structure, that could not be obtained by DLS. The SAXS diagrams of plain and antibiotic-loaded vectors derived from CCY110 bacteria are reported in Figure 1 (a-c); their fitting proved that these systems have the structure of unilamellar liposomes. The best fit parameters are listed in Table 2 .
The bilayer head-to-head thickness (2ZH = 46 Å) of plain CCY-lipo was only slightly Similar results were obtained for 42OL-liposomes (Figure 2 ), therefore we concluded that the insertion modality of Amp and PenG in the membranes derived from these capsule-free bacteria was similar. The best fit parameters obtained for these samples are also reported in Table 4 . The liposomes prepared from VI22 bacteria had a slightly different structure, as it could already be inferred from fitting the diagram of plain VI22-lipo (Figure 3 ).
Indeed the polar layer of VI22-lipo was markedly thicker that other PD-liposomes (see Table 2 ), probably as a consequence of some molecules composing the outer polyglycan envelope being retained in the extracted lipid mixture.
Loading VI22-lipo with antibiotics appeared to increase the thickness of the outer layer, though a complete fitting of the scattering pattern was not possible and only be also ascribed to low SAXS intensity. As an example to illustrate this point, Figure   4 shows the experimental diagrams of samples VI22-lipo + PenG. It is worth noticing that none of the systems studied in this work showed quasi long-range order, which allowed to infer that multilamellar liposomes were not present in PD-liposome samples. Indeed, the SAXS signal of multi-or oligolamellar structures is much narrower than the pattern of monolamellar liposomes, so that their presence is unambiguosly revealed by Bragg peaks, even if there is coexistance of theses two types of aggregates and monolamellae are by far the major component (e.g. 98-99%).
In summary, the structural investigation of PD-liposomes proved that these novel 
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This part is very unclear and difficult to read The lack of increase in the antimicrobial efficacy of CCY-, VI22-and 42OL-liposomes loaded with Amp with respect to free Amp (for all antibiotic formulation the MIC was 14.5 μg/mL) could be explained by the greater OM permeability to
Amp as compared to PenG. In fact, the permeability of Amp was reported to be four times higher than PenG, a behavior attributed to differences in the gross physicochemical properties (liposome size, charge and lipophilicity) of these two molecules, that influenced their passage through the porin channel. 72, 73 Accordingly, we found E. coli XL1Blue strain to be more resistant to free PenG than to free Amp, with exactly 4-fold difference in MIC values (58 μg/ml and 14.5 μg/ml, respectively). Therefore, also the loaded antibiotic can play a role in the evaluation of the efficiency of such vectors, suggesting that each new formulation must be targeted to both the molecules and microorganisms under consideration.
Noteworthy, antibiotic loaded PD-liposomes did not exert any inhibition on the E. 74 PD-liposomes could be tested not only to counteract intrinsic mechanisms of antibiotic resistance, such as that of Gram-negative bacteria to β-lactams, but also for preventing or inhibiting microbial biofilm formation.
